Lanean...
Current Clinical Trials in Non-Muscle Invasive Bladder Cancer (NIMBC)
BACKGROUND: The treatment options for non-muscle invasive bladder cancer (NMIBC) remain limited. BCG was the last major breakthrough in bladder cancer therapy almost 4 decades ago. There have been improvements in the understanding of immune therapies and cancer biology, leading to the development of...
Gorde:
| Argitaratua izan da: | Urol Oncol |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5556973/ https://ncbi.nlm.nih.gov/pubmed/28778250 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urolonc.2017.06.043 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|